- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 54.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 47.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.48M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $119.8K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$594.15K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$46.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$48.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$80.85M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$80.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.6M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.6M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.51M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $807.78K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.64M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $815.83K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $997.01K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.07M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.02M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$308.08K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.81M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.36M |